Université de Picardie Jules Verne
33 imported, source-linked research records. Open-access records.
33 matching research records
Topic: Klotho therapies. Only records linked to Université de Picardie Jules Verne are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–33 of 33 matching records. Counts update as records arrive.
Copper Impedes Calcification of Human Aortic Vascular Smooth Muscle Cells Through Inhibition of Osteogenic Transdifferentiation and Promotion of Extracellular Matrix Stability
April 1, 2025 · 1 citations · Open access
Open original record →Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies
March 1, 2025 · 16 citations · Open access
Open original record →The role of the intestinal microbiome in cognitive decline in patients with kidney disease
March 1, 2025 · 14 citations · Open access
Open original record →The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial
November 13, 2024 · 0 citations · Open access
Open original record →Impact de l'indoxyl sulfate sur la calcification des cellules interstitielles de la valve aortique humaine
October 23, 2024 · 0 citations · Open access
Open original record →Severe hypophosphatemia induced by excessive production of FGF23 in acute hepatitis: from bedside to bench
October 9, 2024 · 3 citations · Open access
Open original record →Cognitive impairment in CKD patients: a guidance document by the CONNECT network
September 30, 2024 · 33 citations · Open access
Open original record →Animal models to study cognitive impairment of chronic kidney disease
April 18, 2024 · 9 citations · Open access
Open original record →The AKI-to-CKD Transition: The Role of Uremic Toxins
November 10, 2023 · 32 citations · Open access
Open original record →Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2
July 30, 2023 · 21 citations · Open access
Open original record →Rôle des toxines urémiques dans la genèse des complications de la maladie rénale chronique
January 25, 2023 · 0 citations · Open access
Open original record →Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
September 15, 2022 · 26 citations · Open access
Open original record →Vasorin plays a critical role in vascular smooth muscle cells and arterial functions
July 26, 2022 · 15 citations · Open access
Open original record →The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury
May 11, 2022 · 18 citations · Open access
Open original record →Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
April 14, 2022 · 65 citations · Open access
Open original record →Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease
July 6, 2021 · 39 citations · Open access
Open original record →The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
June 17, 2020 · 10 citations · Open access
Open original record →New insights in osteocyte imaging by synchrotron radiation
January 16, 2020 · 12 citations · Open access
Open original record →The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
May 17, 2019 · 30 citations · Open access
Open original record →Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
June 5, 2018 · 46 citations · Open access
Open original record →The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function
May 29, 2018 · 105 citations · Open access
Open original record →The expanding roles of microRNAs in kidney pathophysiology
April 26, 2018 · 42 citations · Open access
Open original record →Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD
October 26, 2017 · 51 citations · Open access
Open original record →Higher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes
June 8, 2017 · 8 citations · Open access
Open original record →Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism
January 10, 2017 · 160 citations · Open access
Open original record →Pro: Cardiovascular calcifications are clinically relevant
February 23, 2015 · 56 citations · Open access
Open original record →Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
April 2, 2014 · 140 citations · Open access
Open original record →The quest for a better understanding of chronic kidney disease complications: an update on uremic toxins
January 1, 2014 · 58 citations · Open access
Open original record →Vascular Toxicity of Phosphate in Chronic Kidney Disease
January 1, 2014 · 62 citations · Open access
Open original record →Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
September 5, 2013 · 59 citations · Open access
Open original record →Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure
April 17, 2013 · 58 citations · Open access
Open original record →Effects of phosphate on vascular function under normal conditions and influence of the uraemic state
July 20, 2012 · 98 citations · Open access
Open original record →Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice
June 24, 2011 · 57 citations · Open access
Open original record →
